Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 906 record(s)

Req # A-2023-00019

All documents, meetings, correspondence and communications concerning the approval case of the planned merger between TD Bank and First Horizon for the time period May 5, 2022 through May 31, 2023 including those between OSFI and any representative of First Horizon and/or TD; and between OSFI and any regulators.

Organization: Office of the Superintendent of Financial Institutions Canada

66 page(s)
April 2024

Req # A-2023-00023

All documents, meetings, correspondence and communications concerning TD’s regulatory compliance for the time period August 18, 2022 through the present (September 14, 2023), including concerning how TD's regulatory compliance may have impacted the planned merger between TD Bank and First Horizon.

Organization: Office of the Superintendent of Financial Institutions Canada

13 page(s)
April 2024

Req # A-2023-00035

Supervision and Policy Oversight Committee Jan 10, 2024 Reference

Organization: Office of the Superintendent of Financial Institutions Canada

74 page(s)
April 2024

Req # A-2019-000270

Adverse Drug Reactions (ADRs). Report numbers: 000146129, 000191438, 000335588, 000335771, 000338151, 000345474, 00389283, 000390319, 000593310, E2B_00570261, E2B_00570262, E2B_00570263, E2B_00570264.

Organization: Health Canada

81 page(s)
February 2024

Req # A-2020-000388

Adverse Drug Reactions (ADRs). Report numbers: E2B_02731350, E2B_02777680, E2B_02810755, E2B_02838946, E2B_02852030, E2B_02856401, E2B_02777244, 000735201, E2B_02869967, E2B_02869987, E2B_02869946, E2B_02871897, E2B_02871900, E2B_02871882, E2B_02871883.

Organization: Health Canada

185 page(s)
February 2024

Req # A-2020-000647

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000736259, 000738096, 000911912, E2B_02993730, E2B_03001785, E2B_03004317, E2B_03005410, E2B_03015111, E2B_03020794, E2B_03024205, E2B_03034122, E2B_03038830, E2B_03047792. ADRs for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_03047105, E2B_03003181, E2B_03005697, 000908663. ADR for PANTOPRAZOLE SODIUM. Report number: E2B_03045008. ADR for TECTA. Report number: E2B_03014229.

Organization: Health Canada

563 page(s)
February 2024

Req # A-2020-000731

Adverse Drug Reactions (ADRs) for Estrogel. Report numbers: 000693076, E2B_002778333. ADR for Ezetrol. Report number: E2B_01181304. ADRs for Fosamax. Report numbers: 000675450, 00685185, E2B_00037382, 000518360, 000555402, 000543195, E2B_00256053, E2B_00066044.

Organization: Health Canada

221 page(s)
February 2024

Req # A-2020-000800

Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_00498826, E2B_00498902, E2B_00500827, E2B_00506460, E2B_00786970, E2B_00894613, E2B_00894617, E2B_00894629, E2B_00896465, E2B_00898784, E2B_00898796, E2B_00898918, E2B_00941125, E2B_00944258, E2B_00946463, E2B_00947254, E2B_00786948, E2B_00792724, E2B_01103249, E2B_01104135.

Organization: Health Canada

1365 page(s)
February 2024

Req # A-2020-000870

Adverse Drug Reactions (ADRs). Report numbers: E2B_01674763, E2B_02137119, 000723810, 000724215, 000724308, 000724654, 000724751, E2B_02429833, E2B_02438547, E2B_02304224, E2B_02304226, E2B_02359312.

Organization: Health Canada

98 page(s)
February 2024

Req # A-2020-001098

Adverse Drug Reactions (ADRs). Report numbers: E2B_02122343, E2B_02124829, E2B_02125454, E2B_02124823, E2B_02198090, E2B_02174028, E2B_02198927, E2B_02251024, E2B_02262610, E2B_02268152,E2B_02236011, E2B_02302657, E2B_02312268, E2B_02272665, E2B_02296322, E2B_02304916, E2B_02296326, E2B_02296362, E2B_02297747, E2B_02427141.

Organization: Health Canada

314 page(s)
February 2024
Date modified: